PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
1.2
AUD
-3.23%
Market Closed
Market Cap:
699.9m
AUD
Section:
Wall Street
Price Targets
Price Target
Average
+40%
Revenue
Forecast
+23%
Operating Income
Forecast
N/A
Net Income
Forecast
+93%
Wall Street
Price Targets
PYC Price Targets Summary
PYC Therapeutics Ltd
PYC Therapeutics Ltd
Wall Street analysts forecast PYC stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
PYC
is 3.48 AUD
with a low forecast of 2.32 AUD and a high forecast of 5.01 AUD.
Lowest
Price Target
2.32
AUD
94% Upside
Average
Price Target
3.48
AUD
190% Upside
Highest
Price Target
5.01
AUD
318% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PYC's stock price target?
Price Target
3.48
AUD
3.48
AUD
According to Wall Street analysts, the average 1-year price target for
PYC
is 3.48 AUD
with a low forecast of 2.32 AUD and a high forecast of 5.01 AUD.
What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
-7%
-7%
The
compound annual growth rate
of PYC Therapeutics Ltd's revenue for the next 3 years is
-7%.
You don't have any saved screeners yet
